Concepedia

Clarissa Martinez

CM

Statistics

Publications

6

Citations

199

H-Index

6

Active since

2002

Affiliations

Vaxart (United States)(Current)

Biomedical Research Institute

Lovelace Respiratory Research Institute

Duke University

Clarissa Martinez is an author at Vaxart (United States) specializing in medicine, viral immunity, and covid-19.

ORCID

Top concepts

Publications per year

2002–2023

6

Publications

6

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model

Stephanie N. Langel, Susan Johnson, Clarissa Martinez et al. · Science Translational Medicine · 2022 · 114 citations · Full text

, , +14

Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model

Susan Johnson, Clarissa Martinez, Sarah N. Tedjakusuma et al. · The Journal of Infectious Diseases · 2021 · 35 citations · Full text

SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial

Susan Johnson, Clarissa Martinez, Clara B Jegede et al. · 2022 · 19 citations · Full text

, , +17

Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model

Stephanie N. Langel, Susan Johnson, Clarissa Martinez et al. · 2021 · 11 citations · Full text

, , +13

Effect of kainic acid-induced seizures on sleep patterns.

Fructuoso Ayala‐Guerrero, A. Alfaro, Clarissa Martinez et al. · PubMed · 2002 · 10 citations

, , +10

1–5 of 6